MedTrace Logo

Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART)

NCT00518141 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2011-07-21

No results posted yet for this study

Summary

This study aims to determine the possible effects of Acetyl Salicylic Acid (ASA) and Terbutalin on ART treatment.

Conditions

  • Reproductive Techniques, Assisted

Interventions

DRUG

Acetyl Salicylic Acid and Terbutalin

ASA 75 mg, Terbutalin 5mg

Sponsors & Collaborators

  • Sykehuset Telemark

    lead OTHER_GOV

Principal Investigators

  • Jarl A Kahn, Dr. med · STHF, Kvinneklinikken, Fertilitetsklinikken Sor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00518141 on ClinicalTrials.gov